Aligos Therapeutics, Inc. (ALGS)
NASDAQ: ALGS · Real-Time Price · USD
5.57
+0.07 (1.27%)
At close: Jun 26, 2026, 4:00 PM EDT
5.46
-0.11 (-1.94%)
After-hours: Jun 26, 2026, 7:52 PM EDT
Aligos Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Aligos Therapeutics stock have an average target of 59.67, with a low estimate of 20 and a high estimate of 175. The average target predicts an increase of 971.27% from the current stock price of 5.57.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Aligos Therapeutics stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 4 | 4 | 4 | 6 | 6 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 5 | 5 | 5 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $50 | Buy | Reiterates | $50 | +797.67% | Jun 4, 2026 |
| Lake Street | Lake Street | Buy Maintains $45 | Buy | Maintains | $45 | +707.90% | Jun 1, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $20 | Buy | Maintains | $20 | +259.07% | May 29, 2026 |
| Piper Sandler | Piper Sandler | Buy Maintains $175 | Buy | Maintains | $175 | +3,041.83% | May 8, 2026 |
| Jefferies | Jefferies | Buy Initiates $48 | Buy | Initiates | $48 | +761.76% | Mar 19, 2026 |
Financial Forecast
Revenue This Year
21.68M
from 2.19M
Increased by 891.61%
Revenue Next Year
5.00M
from 21.68M
Decreased by -76.93%
EPS This Year
-7.11
from -2.45
EPS Next Year
-4.00
from -7.11
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 36.8M | 21.0M | |
| Avg | 21.7M | 5.0M | |
| Low | 2.8M | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1,584.8% | -3.1% | |
| Avg | 891.6% | -76.9% | |
| Low | 29.5% | -100.0% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | -7.11 | -4.00 | |
| Low | - | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.